Sinus Infection Clinical Trial
Official title:
Epidemiological Study of Non-invasive Fungal Sinusitis as Presented in Sohag University Hospital
Verified date | October 2021 |
Source | Sohag University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
in this study, the investigators will collect data from patients with non-invasive fungal sinusitis to know what causes it
Status | Enrolling by invitation |
Enrollment | 70 |
Est. completion date | August 2022 |
Est. primary completion date | August 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Patients with Acute fungal sinusitis. - Patients with chronic granulomatous sinusitis. - Patients with sinus mycetomas. Exclusion Criteria: - Immunocompromised patients. - invasive fungal sinusitis. |
Country | Name | City | State |
---|---|---|---|
Egypt | Sohag University Hospital | Sohag |
Lead Sponsor | Collaborator |
---|---|
Sohag University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | risk factors related to non-invasive fungal sinusitis | retrospective study assessed by Statistical Package for Social Sciences | 5 years study period from august 2016 to august 2021 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06076304 -
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis
|
Phase 4 | |
Recruiting |
NCT03729258 -
Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.
|
Phase 3 | |
Recruiting |
NCT05454072 -
Microbiota Transfer for Chronic Rhinosinusitis
|
N/A | |
Enrolling by invitation |
NCT05954273 -
Maxillary Sinus Membrane Perforation Incidence During Osseodensification
|